Could AI chip boom make ASML Europe's first trillion-dollar firm?

AMSTERDAM, July 20 (Reuters) - The global artificial intelligence boom has propelled ASML to the top of Europe's stock market, as soaring demand for AI computer chips flows to the Dutch company that dominates the market for the equipment needed to make them. After blowout second quarter earnings, investors and analysts are asking a once far-fetched question: could ASML become Europe's first ever trillion-dollar firm? Key obstacles include doubts over how long Google, Amazon, and other hyperscalers will keep spending heavily on data centres, and whether ASML, its suppliers and customers such as TSMC and Samsung can execute expansion plans. But after ASML shares spiked 60% this year to push the firm close to a $700 billion valuation, investors and analysts say the trillion-dollar scenario is plausible. "I think it has a really good chance of being the first company in Europe to hit the trillion mark," said Carolyn Bell, lead portfolio manager for Stonehage Fleming's Global Best Ideas, adding ASML accounted for about 8% of the portfolio. "I just don't know when." Shares trade at 38 times forecast earnings for 2027, according to LSEG data, well above multiples for top ASML customer TSMC, which manufactures the AI chips designed by Nvidia and used by OpenAI, Anthropic and the hyperscaler firms. ASML investors and analysts said to justify the premium and grow into that valuation several things need to go right, notably continuing hyperscaler demand. Trent Masters of Alphinity Investment Management, which has about 3% of its portfolio in ASML, warned that "any cooling of this will flow through to ASML's earnings". He said other threats include ASML's ability to manage its supply chain and geopolitical risks, though he is "on balance very positive" about the company's outlook. U.S. lawmakers have proposed the MATCH Act, a law that could curtail ASML's sales and servicing of equipment in China - a market where ASML expects to have 20% of sales in 2026. Analysts said there are also reasons ASML could keep growing even amid an AI slowdown. Kinngai Chan of Summit Insights Group said AI memory chip makers such as SK Hynix, Samsung and Micron are shifting production away from processes that use ASML's older DUV tools toward new and pricier EUV tools, a profitable "upgrade cycle". ASML "can surely be" Europe's first trillion-dollar firm, ING analyst Marc Hesselink said. And then there is the possibility that chip demand accelerates. The new Terafab plant planned by Elon Musk in Texas to supply SpaceX and Tesla represents a new source of revenue for ASML. Antoine Hucher of Aviva Investors said if the company executed its strategy well and AI demand held up, ASML would keep growing, though nothing was certain. "ASML could well become the first European company to reach a $1 trillion market cap," he said. "However, the volatility we have seen with AI stocks in the last few weeks suggests the journey to this achievement won't be a straight line." Analyst upgrades after the second quarter show it's no pipe dream. Barclays, Susquehanna and Bernstein now have 12-month price targets above $2,600 per share - a 49% rise from current levels and the rough threshold for a $1 trillion market cap. ASML is the only seller of extreme ultraviolet (EUV) lithography tools required to print the minute circuitry of the most advanced logic and memory chips. Investors compare its business to selling picks and shovels during a gold rush. John Lamb of Capital Group, whose funds hold around 5% of ASML shares worth $35 billion, praised it as a long-term holding for its "unique assets and wide moats". "The fundamentals for the industry as a whole appear stronger than ever and ASML occupies a critical space," he said. ASML has overtaken and is now streaking away from other leading European companies Roche, LVMH, Novo Nordisk, AstraZeneca and SAP.

Could AI chip boom make ASML Europe's first trillion-dollar firm?

ASML rises on AI chip demand

What could help or hurt further gains

Analysts point to pricing and valuation

Related News

Magnolia Oil & Gas slides after starting $1 bln stock offering for WildFire Energy deal

Fairmount Healthcare Fund II LP acquires 853,450 Crescent Biopharma shares for $12.38 million

Fastly CEO Charles Lacey Compton III sells USD 386,550 in common shares

Compass Digital Acquisition holds shareholder meeting on adjournment proposal

Cracker Barrel expects annual results above forecast, sells part of Maple Street chain